AfterMASH is regarded as one of the worst spinoffs ever produced, but its co-creator thinks one big change could have fixed its problems.

The result suggests that the protein made by the gene, known as Nwd1, and other molecules it interacts with could be worthwhile targets for new MASH therapies. The scientists published their work ...